tiprankstipranks
Advertisement
Advertisement

SFOSF Stock Latest News

Fosun Pharma Subsidiary Wins China Nod for Flurbiprofen Pain Injection
Company AnnouncementsFosun Pharma Subsidiary Wins China Nod for Flurbiprofen Pain Injection
1d ago
Fosun Pharma Sets April Board Meeting to Approve First-Quarter 2026 Results
PremiumCompany Announcements
Fosun Pharma Sets April Board Meeting to Approve First-Quarter 2026 Results
1d ago
Fosun Pharma Wins China Trial Nod for Teva-Partnered Cancer Drug FXB0871
PremiumCompany Announcements
Fosun Pharma Wins China Trial Nod for Teva-Partnered Cancer Drug FXB0871
11d ago
Fosun Pharma Lifts 2025 Profit on Higher Margins and EBITDA
PremiumCompany Announcements
Fosun Pharma Lifts 2025 Profit on Higher Margins and EBITDA
18d ago
Fosun Pharma Proposes 2025 Final Dividend and Details Tax Treatment for H-Share Investors
PremiumCompany Announcements
Fosun Pharma Proposes 2025 Final Dividend and Details Tax Treatment for H-Share Investors
18d ago
SFOSF Earnings this Week: How Will it Perform?
PremiumPre-EarningsSFOSF Earnings this Week: How Will it Perform?
20d ago
Fosun Pharma Subsidiary Wins Approval for Sodium Thiosulfate Antidote Injection
Premium
Company Announcements
Fosun Pharma Subsidiary Wins Approval for Sodium Thiosulfate Antidote Injection
22d ago
Fosun Pharma Unit Wins China Trial Nod for Novel Alopecia Biotherapeutic
Premium
Company Announcements
Fosun Pharma Unit Wins China Trial Nod for Novel Alopecia Biotherapeutic
26d ago
Fosun Pharma Wins NMPA Nod to Start Trials of New Blood Cancer Drug FXS0683
PremiumCompany Announcements
Fosun Pharma Wins NMPA Nod to Start Trials of New Blood Cancer Drug FXS0683
29d ago
Fosun Pharma Sets March 2026 Board Meeting to Approve 2025 Results and Dividend Plan
PremiumCompany Announcements
Fosun Pharma Sets March 2026 Board Meeting to Approve 2025 Results and Dividend Plan
1M ago
Fosun Pharma Reports Strong Shareholder Turnout at 2026 Extraordinary Meetings
PremiumCompany Announcements
Fosun Pharma Reports Strong Shareholder Turnout at 2026 Extraordinary Meetings
1M ago
Fosun Pharma Wins CSRC Nod for Up to RMB6 Billion Tech Innovation Bonds
PremiumCompany Announcements
Fosun Pharma Wins CSRC Nod for Up to RMB6 Billion Tech Innovation Bonds
1M ago
Fosun Pharma Wins NMPA Nod for New Lung Cancer Trial of Luvometinib
PremiumCompany AnnouncementsFosun Pharma Wins NMPA Nod for New Lung Cancer Trial of Luvometinib
2M ago
Fosun Pharma Subsidiary Wins NMPA Acceptance for New Anesthetic Drug
Premium
Company Announcements
Fosun Pharma Subsidiary Wins NMPA Acceptance for New Anesthetic Drug
2M ago
Fosun Pharma Subsidiary’s Cisplatin Injection Application Accepted by Chinese Regulator
Premium
Company Announcements
Fosun Pharma Subsidiary’s Cisplatin Injection Application Accepted by Chinese Regulator
2M ago
Fosun Pharma Subsidiary Wins Acceptance of Tetracaine Gel Registration in China
PremiumCompany Announcements
Fosun Pharma Subsidiary Wins Acceptance of Tetracaine Gel Registration in China
2M ago
Fosun Pharma Wins Priority Review in China for New Luvometinib Indication
PremiumCompany Announcements
Fosun Pharma Wins Priority Review in China for New Luvometinib Indication
2M ago
Fosun Pharma Subsidiary’s Cyclophosphamide Injection Application Accepted by Chinese Regulator
PremiumCompany Announcements
Fosun Pharma Subsidiary’s Cyclophosphamide Injection Application Accepted by Chinese Regulator
2M ago
Fosun Pharma Calls 2026 EGM to Advance Spin-off and Hong Kong Listing of Fosun Adgenvax
PremiumCompany Announcements
Fosun Pharma Calls 2026 EGM to Advance Spin-off and Hong Kong Listing of Fosun Adgenvax
2M ago
Fosun Pharma Calls H-Share Vote on Fosun Adgenvax Spin-Off Entitlements
PremiumCompany AnnouncementsFosun Pharma Calls H-Share Vote on Fosun Adgenvax Spin-Off Entitlements
2M ago
Shanghai Fosun Pharma Completes First Tranche of 2026 Innovation Bonds
Premium
Company Announcements
Shanghai Fosun Pharma Completes First Tranche of 2026 Innovation Bonds
2M ago
Fosun Pharma Subsidiary Wins China Approval for Norepinephrine Injection
Premium
Company Announcements
Fosun Pharma Subsidiary Wins China Approval for Norepinephrine Injection
3M ago

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >